Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs Esomeprazole Dual Therapy for H. pylori Eradication
NCT05870683Unknown
- Start
- May 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tegoprazan in Helicobacter pylori infection (2 arms). Primary endpoint: Helicobacter pylori eradication rate. Status: unknown.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05870683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05870683.